244 related articles for article (PubMed ID: 27815935)
21. Epidemiology of hepatitis B, C and D in Malawi: systematic review.
Stockdale AJ; Mitambo C; Everett D; Geretti AM; Gordon MA
BMC Infect Dis; 2018 Oct; 18(1):516. PubMed ID: 30314448
[TBL] [Abstract][Full Text] [Related]
22. The seroprevalence of both hepatitis B and hepatitis C at the first-step health organizations and the difference between the urban and rural areas.
Kalem F; Yüksekkaya Ş; Başaranoğlu M
Wien Klin Wochenschr; 2016 Oct; 128(19-20):695-699. PubMed ID: 25869760
[TBL] [Abstract][Full Text] [Related]
23. [HIVAb, HCVAb and HBsAg seroprevalence among inmates of the prison of Bologna and the effect of counselling on the compliance of proposed tests].
Sabbatani S; Giuliani R; Fulgaro C; Paolillo P; Baldi E; Chiodo F
Epidemiol Prev; 2004; 28(3):163-8. PubMed ID: 15532873
[TBL] [Abstract][Full Text] [Related]
24. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.
Acar A; Kemahli S; Altunay H; Kosan E; Oncul O; Gorenek L; Cavuslu S
Transfus Med; 2010 Jun; 20(3):152-9. PubMed ID: 20059750
[TBL] [Abstract][Full Text] [Related]
25. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
26. 2017 European guideline for the screening, prevention and initial management of hepatitis B and C infections in sexual health settings.
Brook G; Brockmeyer N; van de Laar T; Schellberg S; Winter AJ
Int J STD AIDS; 2018 Sep; 29(10):949-967. PubMed ID: 29716442
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of Hepatitis B virus and/or Hepatitis C virus co-infections in prisoners infected with the Human Immunodeficiency Virus.
Pontali E; Ferrari F
Int J Prison Health; 2008; 4(2):77-82. PubMed ID: 18464061
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis virus infection in haemodialysis patients from Moldavia.
Covic A; Iancu L; Apetrei C; Scripcaru D; Volovat C; Mititiuc I; Covic M
Nephrol Dial Transplant; 1999 Jan; 14(1):40-5. PubMed ID: 10052474
[TBL] [Abstract][Full Text] [Related]
29. [Health professionals' perceptions and screening for hepatitis B and C among migrants: a qualitative study in Côte-d'Or, France].
Enel C; Minello A; Hillon P
Sante Publique; 2012; 24(4):303-15. PubMed ID: 23043737
[TBL] [Abstract][Full Text] [Related]
30. Surveillance and epidemiology of hepatitis B and C in Europe - a review.
Rantala M; van de Laar MJ
Euro Surveill; 2008 May; 13(21):. PubMed ID: 18761967
[TBL] [Abstract][Full Text] [Related]
31. [Hepatitis B and C infection in late repatriates].
Holbach M; Frösner GG; Holbach B; Dittmeier E
MMW Fortschr Med; 2004 Aug; 146 Suppl 2():81-5. PubMed ID: 16739364
[TBL] [Abstract][Full Text] [Related]
32. The influence of alcohol consumption and hepatitis B and C infections on the risk of liver cancer in Europe.
Ribes J; Clèries R; Esteban L; Moreno V; Bosch FX
J Hepatol; 2008 Aug; 49(2):233-42. PubMed ID: 18571275
[TBL] [Abstract][Full Text] [Related]
33. Strategies for Expanding Access to HBV and HCV Testing and Care in the United States: The CDC Hepatitis Testing and Linkage to Care Initiative, 2012-2014.
Ward JW
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):1-4. PubMed ID: 27168654
[No Abstract] [Full Text] [Related]
34. Will a quadruple multiplexed point-of-care screening strategy for HIV-related co-infections be feasible and impact detection of new co-infections in at-risk populations? Results from cross-sectional studies.
Pai NP; Dhurat R; Potter M; Behlim T; Landry G; Vadnais C; Rodrigues C; Joseph L; Shetty A
BMJ Open; 2014 Dec; 4(12):e005040. PubMed ID: 25510882
[TBL] [Abstract][Full Text] [Related]
35. What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.
Ward JW; Hinman AR
Gastroenterology; 2019 Jan; 156(2):297-310. PubMed ID: 30391470
[TBL] [Abstract][Full Text] [Related]
36. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
Kusendová K; Gavorník P; Sabaka P; Sviteková K
Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
[TBL] [Abstract][Full Text] [Related]
37. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
Japanese Red Cross NAT Screening Research Group
Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
[TBL] [Abstract][Full Text] [Related]
38. Challenges and priorities in the management of HIV/HBV and HIV/HCV coinfection in resource-limited settings.
Easterbrook P; Sands A; Harmanci H
Semin Liver Dis; 2012 May; 32(2):147-57. PubMed ID: 22760654
[TBL] [Abstract][Full Text] [Related]
39. Limited access to hepatitis B/C treatment among vulnerable risk populations: an expert survey in six European countries.
Falla AM; Veldhuijzen IK; Ahmad AA; Levi M; Hendrik Richardus J
Eur J Public Health; 2017 Apr; 27(2):302-306. PubMed ID: 27542982
[TBL] [Abstract][Full Text] [Related]
40. Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review.
Papatheodoridis GV; Tsochatzis E; Hardtke S; Wedemeyer H
Liver Int; 2014 Nov; 34(10):1452-63. PubMed ID: 24750532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
